Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Oral Contraceptive Pills Market?

The market for oral contraceptive pills has seen a significant surge in its size in the past few years. The size of this market is forecasted to increase from $26.82 billion in 2024 to $30.7 billion in 2025, implying a CAGR of 14.5%. The factors attributing to the growth during the historic period include increased awareness, growing concerns about women’s health, initiatives by the government, shifts in lifestyle, and market expansion.

What Growth Rate Is Forecasted for the Oral Contraceptive Pills Market by 2029?

Expectations for the oral contraceptive pills market indicate a swift expansion in the coming years, with its worth expected to hit $54.21 billion in 2029, thanks to a compound annual growth rate (CAGR) of 15.3%. Factors contributing to this surge during the forecast period include population growth, women’s empowerment, increased healthcare spending, advancements in healthcare structure, and a broadened product range. Future trends include an emphasis on reducing side effects and hormonal disturbances, the introduction of non-hormonal and natural contraceptive alternatives, a shift towards uninterrupted and personalized contraceptive plans, increased awareness and education efforts, and a rise in women’s empowerment and decision-making in contraceptive selection.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3900&type=smp

Which Key Companies Are Shaping the Future of the Oral Contraceptive Pills Market?

Major companies operating in the oral contraceptive pills market include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Abbvie Inc., Bayer AG, Zydus Lifesciences Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc., Glenmark Pharmaceuticals, Mankind Pharma Ltd., Mayne Pharma, HLL Lifecare Limited, Famy Care Ltd., Mylan N.V., Novartis AG, GlaxoSmithKline plc, Piramal Enterprises Ltd., Syzygy Healthcare, V Care Pharma

Which Factors Are Driving Demand in the Oral Contraceptive Pills Industry?

The elevated occurrence of unplanned pregnancies is anticipated to fuel the expansion of the oral contraceptive pills market in future years. An unplanned pregnancy is one that is always undesired, such as when there’s no plan for any children. A study by the University of California, San Francisco (UCSF) revealed that the prevalence of unwanted pregnancies and abortions notably dropped when women were given a one-year prescription for oral contraceptives. The World Health Organization (WHO) reports that 74 million women in low to middle-income economies experience unplanned pregnancies annually worldwide. The study done by WHO noted that 4,794 women encountered unplanned pregnancies after they ceased usage of contraceptives. Consequently, the requirement to evade unplanned pregnancies is driving the growth of the oral contraceptive pills market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3900&type=smp

How Is the Oral Contraceptive Pills Market Segmented by Several Divisions?

The oral contraceptive pills market covered in this report is segmented –

1) By Type: Combination, Progestin Only, Other Types

2) By Category: Generic, Branded

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels

Subsegments:

1) By Combination Pills: Monophasic Combination Pills, Multiphasic Combination Pills, Extended-Cycle Combination Pills

2) By Progestin-Only Pills: Daily Progestin-Only Pills, Progestin-Only Emergency Contraceptive Pills

3) By Other Types: Low-Dose Oral Contraceptive Pills, High-Dose Oral Contraceptive Pills, Non-Hormonal Oral Contraceptives (In Development Or Alternative Formulations)

What are the Emerging Market Trends Driving the Growth of the Oral Contraceptive Pills Industry?

Prominent organizations and corporations in the oral contraceptive pill industry are concentrating on creating advanced solutions for oral contraceptive pills. For example, in December 2023, The United Kingdom initiated clinical trials for a male contraception pill which is free of hormones. This unprecedented trial situates the research team in the country as a worldwide pioneer in examining this novel class of drug. The drug, YCT-529, functions as a retinoic acid receptor-alpha inhibitor, disrupting sperm production by blocking access to vitamin A. The drug was developed by a group of scientists from the University of Minnesota in Minneapolis.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Which Regions Are Driving Growth in the Oral Contraceptive Pills Market?

North America was the largest region in the oral contraceptive pills market in 2024. The Middle East is expected to be the largest growing region in the forecast period. The regions covered in the oral contraceptive pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3900

This Report Delivers Insight On:

1. How big is the oral contraceptive pills market, and how is it changing globally?

2. Who are the major companies in the oral contraceptive pills market, and how are they performing?

3. What are the key opportunities and risks in the oral contraceptive pills market right now?

4. Which products or customer segments are growing the most in the oral contraceptive pills market?

5. What factors are helping or slowing down the growth of the oral contraceptive pills market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model